Aging adipose tissue, insulin resistance, and type 2 diabetes

被引：15

作者：

Zhao, Yixuan ^{[1
]}

Yue, Rensong ^{[1
]}

机构：

[1] Hosp Chengdu Univ Tradit Chinese Med, 39 Shi Er Qiao Rd, Chengdu 610072, Sichuan, Peoples R China

来源：

BIOGERONTOLOGY | 2024年 / 25卷 / 01期

关键词：

Aging; Type; 2; diabetes; Insulin resistance; Adipose tissue; FREE FATTY-ACID; GLUCOSE-INTOLERANCE; SUBCUTANEOUS FAT; ADIPOCYTE DIFFERENTIATION; INFLAMMATORY MARKERS; OXIDATIVE STRESS; BODY-FAT; CELLS; BROWN; ASSOCIATION;

D O I：

10.1007/s10522-023-10067-6

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

With the increase of population aging, the prevalence of type 2 diabetes (T2D) is also rising. Aging affects the tissues and organs of the whole body, which is the result of various physiological and pathological processes. Adipose tissue has a high degree of plasticity and changes with aging. Aging changes the distribution of adipose tissue, affects adipogenesis, browning characteristics, inflammatory status and adipokine secretion, and increases lipotoxicity. These age-dependent changes in adipose tissue are an important cause of insulin resistance and T2D. Understanding adipose tissue changes can help promote healthy aging process. This review summarizes changes in adipose tissue ascribable to aging, with a focus on the role of aging adipose tissue in insulin resistance and T2D.

引用

页码：53 / 69

页数：17

共 50 条

[31] Insulin resistance and adipose tissue
Wataru Ogawa
Diabetology International, 2023, 14 : 117 - 118
[32] Insulin resistance and adipose tissue
Ogawa, Wataru
DIABETOLOGY INTERNATIONAL, 2023, 14 (02) : 117 - 118
[33] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
Zirui Hao
Yue Sun
Guiping Li
Yuli Shen
Yingzhen Wen
Yan Liu
BMC Endocrine Disorders, 22
[34] Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes
Eric M. Desjardins
Gregory R. Steinberg
Current Diabetes Reports, 2018, 18
[35] Impaired postprandial adipose tissue blood-flow may be an early marker of insulin resistance in type 2 diabetes
Lambadiari, V.
Dimitriadis, G.
Mitrou, P.
Boutati, E.
Maratou, I.
Panagiotakos, D.
Economopoulos, T.
Raptis, S. A.
DIABETOLOGIA, 2007, 50 : S293 - S293
[36] The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes
Antonio-Villa, N. E.
Bello-Chavolla, O. Y.
Vargas-Vazquez, A.
Mehta, R.
Aguilar-Salinas, C. A.
DIABETIC MEDICINE, 2020, 37 (07) : 1192 - 1201
[37] Progression from High Insulin Resistance to Type 2 Diabetes Does Not Entail Additional Visceral Adipose Tissue Inflammation
Barbarroja, Nuria
Lopez-Pedrera, Chary
Garrido-Sanchez, Lourdes
Dolores Mayas, Maria
Oliva-Olivera, Wilfredo
Rosa Bernal-Lopez, Maria
El Bekay, Rajaa
Jose Tinahones, Francisco
PLOS ONE, 2012, 7 (10):
[38] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
Hao, Zirui
Sun, Yue
Li, Guiping
Shen, Yuli
Wen, Yingzhen
Liu, Yan
BMC ENDOCRINE DISORDERS, 2022, 22 (01)
[39] FKBP5 gene polymorphisms and expression in human adipose tissue are associated with insulin resistance and type 2 diabetes
Pereira, M. J.
Palming, J.
Svensson, M. K.
Rizell, M.
Dalenback, J.
Hammar, M.
Fall, T.
Sidibeh, C. O.
Svensson, P. -A.
Eriksson, J. W.
DIABETOLOGIA, 2014, 57 : S239 - S239
[40] Exploration of the molecular mechanism of insulin resistance in adipose tissue of patients with type 2 diabetes mellitus through a bioinformatic analysis
Wang, Yujing
Zhou, Weiyu
Liu, Dana
Zhang, Zhiying
Xu, Yuanxin
Wan, Xiaojing
Yu, Haiqiao
Yan, Shuang
MINERVA ENDOCRINOLOGY, 2023, 48 (04): : 440 - 446

← 1 2 3 4 5 →